Castleman J, Gurney L, Kilby M, et al. Identification and management of fetal anaemia: a practical guide. Obstet Gynaecol. 2021;23:196–205.
Agarwal K, Rana A, Ravi AK. Treatment and prevention of Rh isoimmunization. J Fetal Med. 2014;1:81–8. https://doi.org/10.1007/s40556-014-0013-z.
Sahoo T, Sahoo M, Gulla KM, et al. Rh alloimmunisation: current updates in antenatal and postnatal management. Indian J Pediatr. 2020;87(12):1018–28. https://doi.org/10.1007/s12098-020-03366-0. (Epub 2020 Jul 1 PMID: 32607667).
Hawgood BJ. Professor Sir William Liley (1929–83): New Zealand perinatal physiologist. J Med Biogr. 2005;13(2):82–8. https://doi.org/10.1177/096777200501300205. (PMID: 19813309).
Zwiers C, Lindenburg ITM, Klumper FJ, et al. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol. 2017;50(2):180–6. https://doi.org/10.1002/uog.17319 (PMID:27706858; PMCID:PMC5601196).
Article CAS PubMed PubMed Central Google Scholar
Pasman SA, Claes L, Lewi L, et al.. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven. Facts Views Vis Obgyn. 2015;7(2):129–36. PMID: 26175890; PMCID: PMC4498170.
Dadhwal V, Deepika D, Gurunath S, et al. Treatment of fetal anemia in Rh isoimmunized pregnancies with intrauterine fetal blood transfusion. J Obst Gynecol India. 2010;60:135–40. https://doi.org/10.1007/s13224-010-0019-y.
Girelli G, Anton cecchi S, Casadei AM, et al.. Recommendations for transfusion therapy in neonatology. Blood Transfus. 2015;13(3):484–97. https://doi.org/10.2450/2015.0113-15. PMID: 26445308; PMCID: PMC4607607.
Dodd JM, Andersen C, Dickinson JE, et al. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial. Ultrasound Obstet Gynecol. 2018;51:306–12.
Article CAS PubMed Google Scholar
Santiago MD, Rezende CA, Cabral AC, et al. Determining the volume of blood required for the correction of foetal anaemia by intrauterine transfusion during pregnancies of Rh isoimmunised women. Blood Transfus. 2010;8(4):271–7. https://doi.org/10.2450/2010.0151-09 (PMID:20967169; PMCID:PMC2957493).
Article PubMed PubMed Central Google Scholar
Potdar O, Narkhede HR, Satoskar PR. Perinatal outcome after intrauterine transfusion in Rh isoimmunized mothers. J Obstet Gynaecol India. 2019;69(2):123–128. https://doi.org/10.1007/s13224-018-1108-6. Epub 2018 Apr 2. PMID: 30956465; PMCID: PMC6430274.
Yinon Y, Visser J, Kelly EN, et al. Early intrauterine transfusion in severe red blood cell alloimmunization. Ultrasound Obstet Gynecol. 2010;36:601–6. https://doi.org/10.1002/uog.7696.
Article CAS PubMed Google Scholar
Sánchez-Durán MÁ, Higueras MT, Halajdian-Madrid C, et al. Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital. BMC Pregnancy Childbirth. 2019;19(1):356. https://doi.org/10.1186/s12884-019-2525-y (PMID:31615430; PMCID:PMC6794826).
Article CAS PubMed PubMed Central Google Scholar
Al-Riyami AZ, Al-Salmani M, Al-Hashami SN, et al. Intrauterine fetal blood transfusion: descriptive study of the first four years' experience in Oman. Sultan Qaboos Univ Med J. 2018;18(1):e34-e42. https://doi.org/10.18295/squmj.2018.18.01.006. Epub 2018 Apr 4. PMID: 29666679; PMCID: PMC5892811.
Shirazi, M., Feizabad, E., Bahmanpour, G. et al. Short neonatal outcomes after intrauterine transfusion in fetal anemia, the experience from a Referral Academic Center. Iran J Neonatol IJN, 2022;13(4):28–33. https://doi.org/10.22038/ijn.2022.63924.2225
Clarke G. Intrauterine transfusion: an international review of practice and policy. VOXS. 2020;15:342–6. https://doi.org/10.1111/voxs.12552.
Mizuuchi M, Murotsuki J, Ishii K, et al. Nationwide survey of intrauterine blood transfusion for fetal anemia in Japan. J Obstet Gynaecol Res. 2021;47:2076–81. https://doi.org/10.1111/jog.14746.
Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol. 2012;206(2):141.e1-8. https://doi.org/10.1016/j.ajog.2011.09.024. (Epub 2011 Sep 24 PMID: 22030316).
van Kamp IL, Klumper FJ, Bakkum RS, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol. 2001;185(3):668–73. https://doi.org/10.1067/mob.2001.116690. (PMID: 11568796).
Blyth U, Larsson M, Baird A, et al. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review. J Matern Fetal Neonatal Med. 2022;35(25):10220–5. https://doi.org/10.1080/14767058.2022.2122041. (Epub 2022 Sep 18 PMID: 36121063).
Pan W, Wu H, Chen J, et al. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China. Front Pediatr. 2023;12(11):1157004. https://doi.org/10.3389/fped.2023.1157004 (PMID:37124190; PMCID:PMC10130633).
Ree IMC, Lopriore E, Zwiers C, et al. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions. Am J Obstet Gynecol. 2020;223(1):119.e1-119.e10. https://doi.org/10.1016/j.ajog.2020.01.028. (Epub 2020 Jan 21 PMID: 31978433).
Pessler F, Hart D. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin. J Pediatr Hematol Oncol. 2002;24(8):689–93. https://doi.org/10.1097/00043426-200211000-00019. (PMID: 12439047).
Comments (0)